For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Eutropics Pharmaceuticals, Inc.

USPTO Granted Patents = 13

% Expired Patents = 23.1

EPO Patents = 7

Trademarks = 1

Forward Citations = 76

Loading Chart...

Loading Chart...

8 inventors (with patents filed for the assignee):

Michael H Cardone (12 out of 13 patents)

Andrew Kolodziej (4 out of 15 patents)

David James Richard (4 out of 32 patents)

4. Xiang Y Yu (2 out of 35 patents)

5. Anthony Letai (1 out of 15 patents)

6. Elisha J Dettman (1 out of 1 patent)

7. William Edward Pierceall (1 out of 4 patents)

8. Michael Cardone (1 out of 1 patent)

9. Andrew F Kolodziej (0 patent)

13 patents: Sort by Forward Citations

1. 12742764 - METHODS FOR PREDICTING CANCER DRUG RESPONSIVENESS (2026-09-22),

2. 11656230 - Method for predicting cancer sensitivity (2023-05-23),

3. 10793915 - Context dependent diagnostics test for guiding cancer treatment (2020-10-06),

4. 10765673 - Methods and compositions useful for treating diseases involving Bcl-2 family proteins with quinoline derivatives (2020-09-08),

5. 10732182 - Method for predicting cancer sensitivity (2020-08-04),

6. 10640803 - Methods for determining chemosensitivity and chemotoxicity (2020-05-05),

7. 10413549 - Methods and compositions useful for treating diseases involving Bcl-2 family proteins with isoquinoline and quinoline derivatives (2019-09-17),

8. 9360473 - Assay system to identify therapeutic agents (2016-06-07),

9. 9351971 - Substituted 2,2'-biphenazines for treating diseases (2016-05-31),

10. 9345700 - Compositions and methods useful for treating diseases (2016-05-24),

11. 9051305 - Compositions and methods useful for treating diseases (2015-06-09),

12. 8987271 - 2,2'-biphenazine compounds and methods useful for treating disease (2015-03-24),

13. 8168755 - Antibodies specific to heterodimers of Bcl-2 family and uses thereof (2012-05-01),

Eutropics Pharmaceuticals, Inc. is a leading biotechnology company focused on developing innovative diagnostic assays for precision medicine. With a dedication to improving patient outcomes, Eutropics harnesses the power of advanced technologies to develop accurate and reliable biomarker-based assays that aid in the personalized treatment of cancer and other diseases. Through collaboration with clinical researchers and industry partners, Eutropics aims to revolutionize the way diseases are diagnosed and treated, ultimately leading to better lives for patients around the world.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

13 Patents

#192 in Cambridge, MA

#1,441 in Massachusetts

#23,808 in US

#44,950 in the World

Cambridge, MA, United States of America

Eutropics Pharmaceuticals, Inc.

Forward Citations = 76

8 inventors:

Michael H Cardone (12 out of 13 patents)

Andrew Kolodziej (4 out of 15 patents)

David James Richard (4 out of 32 patents)

4. Xiang Y Yu (2 out of 35 patents)

5. Anthony Letai (1 out of 15 patents)

Please report any incorrect information to [email protected]

Loading…